PMC:7755033 / 109375-110687
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1113 | 660-665 | Gene | denotes | spike | Gene:43740568 |
1122 | 649-659 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
1359 | 443-447 | Gene | denotes | ACE2 | Gene:59272 |
1361 | 437-442 | Species | denotes | human | Tax:9606 |
2096 | 795-800 | Gene | denotes | Nsp10 | Gene:43740578 |
2097 | 801-804 | Gene | denotes | Nsp | Gene:43740578 |
2099 | 594-599 | Gene | denotes | spike | Gene:43740568 |
2101 | 458-466 | Species | denotes | SARS-CoV | Tax:694009 |
2102 | 471-481 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
2103 | 585-593 | Species | denotes | SARS-CoV | Tax:694009 |
2105 | 714-722 | Species | denotes | SARS-CoV | Tax:694009 |
2106 | 784-794 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
2107 | 1071-1089 | Species | denotes | Withania somnifera | Tax:126910 |
2108 | 1245-1255 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
2109 | 414-416 | Species | denotes | WS | Tax:126910 |
2110 | 975-977 | Species | denotes | WS | Tax:126910 |
2111 | 0-10 | Chemical | denotes | Nelfinavir | MESH:D019888 |
2112 | 15-24 | Chemical | denotes | lopinavir | MESH:D061466 |
2113 | 134-143 | Chemical | denotes | Lopinavir | MESH:D061466 |
2114 | 148-157 | Chemical | denotes | ritonavir | MESH:D019438 |
2115 | 274-284 | Chemical | denotes | nelfinavir | MESH:D019888 |
2116 | 289-298 | Chemical | denotes | lopinavir | MESH:D061466 |
2117 | 392-404 | Chemical | denotes | withanolides | MESH:D054358 |
2118 | 885-897 | Chemical | denotes | withanolides | MESH:D054358 |
2119 | 910-919 | Chemical | denotes | withanone | MESH:C560597 |
2120 | 68-81 | Disease | denotes | HIV infection | MESH:D015658 |
2121 | 230-234 | Disease | denotes | MERS | MESH:D018352 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1106 | 0-133 | Sentence | denotes | Nelfinavir and lopinavir are viral protease inhibitors used against HIV infection but are reported to possess high cytotoxic effects. |
T1107 | 134-329 | Sentence | denotes | Lopinavir and ritonavir are viral protease inhibitors recommended for the treatment of SARS and MERS having similar mechanisms of action as nelfinavir and lopinavir. (Miyamoto and Kollman, 1992). |
T1108 | 330-500 | Sentence | denotes | To elucidate the binding affinity, docking studies of various withanolides found in WS were carried out on human ACE2 receptor, SARS-CoV and SARS-CoV-2 specific proteins. |
T1109 | 501-637 | Sentence | denotes | Among various phytoconstituents, withanolide A displayed strong binding affinity to SARS-CoV spike glycoprotein (BE: −9.78 kcal/mol, Kd: |
T1110 | 638-703 | Sentence | denotes | 67.23 nM), SARS-CoV-2 spike glycoprotein (BE: −7.18 kcal/mol, Kd: |
T1111 | 704-768 | Sentence | denotes | 5.48 µM), SARS-CoV 3CL-pro main protease (BE:-8.93 kcal/mol, Kd: |
T1112 | 769-841 | Sentence | denotes | 285.01 nM) and SARS-CoV-2 Nsp10/Nsp-16 complex (BE: −10.38 kcal/mol, Kd: |
T1113 | 842-852 | Sentence | denotes | 24.67 nM). |
T1114 | 853-978 | Sentence | denotes | On the basis of binding energy, withanolides A and B and withanone were found to be the most effective phytocomponents in WS. |
T1115 | 979-1312 | Sentence | denotes | The present study reports for the first time the antiviral efficacy of medicinal herbs like Withania somnifera that form the crux of Ayurveda, the Indian traditional system of medicine as a viable alternative to chemosynthetic drugs for preventing/blocking entry of SARS-CoV-2 into host cells and also inhibiting viral main protease. |